Life sciences startup Biodimension secures Rs 8 Cr from IAN Angel Fund, others
Bengaluru-based life sciences startup Biodimension has raised Rs 8 crore in a funding round led by IAN Angel Fund. Existing investor Campus Angels Network, Dr. Sampath Srisailam, and angel investor Aaryan Baid also participated in the round.
The proceeds will be used to accelerate product development, expand laboratory infrastructure, strengthen scientific and commercial teams, and support the commercialization of its products in India and overseas markets.
Founded by Manojkumar S., Ranjith Kumar Velusamy, and Pradeep Arunachalam, Biodimension develops biofabricated human tissue and organoid models as alternatives to animal testing for pharmaceutical, biotechnology, and cosmetic companies.
BioDEpi, BioDFT, BioDPigma, a Pan-Cancer Tumour Microenvironment (TME) Biobank, and Bioassay-as-a-Service (BaaS), which offer human-relevant testing solutions for research, safety evaluation, and drug discovery, are among the startup’s offerings.
According to Biodimension, it has formed partnerships with biotech corporations, pharmaceutical companies, research institutions, and contract research organizations in Singapore and India. The business intends to grow its Bioassay-as-a-Service platform, broaden its capabilities in oncology research, and penetrate new international markets, such as Southeast Asia.
